Today the House Ways and Means Trade Subcommittee held a hearing on U.S-India trade issues. India represents a large market for U.S. manufactured goods exports and it’s important that India is playing by the rules.
The hearing today really looked at how we can strengthen and expand trade and investment with India, as well as what can be done to better protect investors and manufacturers who export and sell in India. It is important to enforce existing disciplines on intellectual property (IP) in the WTO and continually make progress in improving those disciplines. We have yet to reach our full potential for U.S. exports to India and there are several intellectual property risks which need to be resolved.
Testifying on these issues from a manufacturing perspective today was Roy Waldron, senior vice president and chief intellectual property counsel for Pfizer. Mr. Waldron’s duties include protecting the company’s intellectual property portfolio throughout the world. The pharmaceutical industry supports more than 4 million jobs in the United States and exports $46 billion in goods. (continue reading…)